{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:35:02Z","timestamp":1787164502730,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Justus-Liebig-Universit\u00e4t Gie\u00dfen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fibroblast growth factor 23 (FGF-23) has been associated with left ventricular hypertrophy (LVH) and heart failure. However, its role in right ventricular (RV) remodeling and RV failure is unknown. This study analyzed the utility of FGF-23 as a biomarker of RV function in patients with pulmonary hypertension (PH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this observational study, FGF-23 was measured in the plasma of patients with PH (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009627), dilated cardiomyopathy (DCM,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200959), or LVH with severe aortic stenosis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200935). Participants without LV or RV abnormalities served as controls (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200936).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Median FGF-23 plasma levels were higher in PH patients than in healthy controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). There were no significant differences between PH, DCM, and LVH patients. Analysis across tertiles of FGF-23 levels in PH patients revealed an association between higher FGF-23 levels and higher levels of NT-proBNP and worse renal function. Furthermore, patients in the high-FGF-23 tertile had a higher pulmonary vascular resistance (PVR), mean pulmonary artery pressure, and right atrial pressure and a lower cardiac index (CI) than patients in the low tertile (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001 for all comparisons). Higher FGF-23 levels were associated with higher RV end-diastolic diameter and lower tricuspid annular plane systolic excursions (TAPSE) and TAPSE\/PASP. Receiver operating characteristic analysis revealed FGF-23 as a good predictor of RV maladaptation, defined as TAPSE\u2009&lt;\u200917\u00a0mm and CI\u2009&lt;\u20092.5 L\/min\/m\n                      <jats:sup>2<\/jats:sup>\n                      . Association of FGF-23 with parameters of RV function was independent of the glomerular filtration rate in regression analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>FGF-23 may serve as a biomarker for maladaptive RV remodeling in patients with PH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphic abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00392-023-02162-y","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T16:08:53Z","timestamp":1676995733000},"page":"1382-1393","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Fibroblast growth factor 23 as a biomarker of right ventricular dysfunction in pulmonary hypertension"],"prefix":"10.1007","volume":"112","author":[{"given":"Laila","family":"Widmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4379-4424","authenticated-orcid":false,"given":"Stanislav","family":"Keranov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leili","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Liebetrau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Troidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Kriechbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mani","family":"Arsalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel J.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khodr","family":"Tello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Gall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein A.","family":"Ghofrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Guth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian W.","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Nef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"2162_CR1","doi-asserted-by":"publisher","first-page":"204589401989544","DOI":"10.1177\/2045894019895446","volume":"9","author":"H Bouzina","year":"2019","unstructured":"Bouzina H, Hesselstrand R, Radegran G (2019) Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension. Pulm Circ 9:2045894019895446. https:\/\/doi.org\/10.1177\/2045894019895446","journal-title":"Pulm Circ"},{"key":"2162_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1183\/09031936.00148310","volume":"38","author":"A Campo","year":"2011","unstructured":"Campo A, Mathai SC, Le Pavec J, Zaiman AL, Hummers LK, Boyce D, Housten T, Lechtzin N, Chami H, Girgis RE, Hassoun PM (2011) Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension. Eur Respir J 38:359\u2013367. https:\/\/doi.org\/10.1183\/09031936.00148310","journal-title":"Eur Respir J"},{"key":"2162_CR3","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s10741-020-09940-0","volume":"26","author":"BO Cojan-Minzat","year":"2021","unstructured":"Cojan-Minzat BO, Zlibut A, Agoston-Coldea L (2021) Non-ischemic dilated cardiomyopathy and cardiac fibrosis. Heart Fail Rev 26:1081\u20131101. https:\/\/doi.org\/10.1007\/s10741-020-09940-0","journal-title":"Heart Fail Rev"},{"key":"2162_CR4","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1165\/rcmb.2010-0412OC","volume":"45","author":"JI Drake","year":"2011","unstructured":"Drake JI, Bogaard HJ, Mizuno S, Clifton B, Xie B, Gao Y, Dumur CI, Fawcett P, Voelkel NF, Natarajan R (2011) Molecular signature of a right heart failure program in chronic severe pulmonary hypertension. Am J Respir Cell Mol Biol 45:1239\u20131247. https:\/\/doi.org\/10.1165\/rcmb.2010-0412OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2162_CR5","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, Hu M-C, Sloan A, Isakova T, Guti\u00e9rrez OM, Aguillon-Prada R, Lincoln J, Hare JM (2011) FGF23 induces left ventricular hypertrophy. J Clin Investig 121:4393\u20134408","journal-title":"J Clin Investig"},{"key":"2162_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1532-429X-14-11","volume":"14","author":"BH Freed","year":"2012","unstructured":"Freed BH, Gomberg-Maitland M, Chandra S, Mor-Avi V, Rich S, Archer SL, Jamison EB Jr, Lang RM, Patel AR (2012) Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension. J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson 14:11. https:\/\/doi.org\/10.1186\/1532-429X-14-11","journal-title":"J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson"},{"key":"2162_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.rec.2016.01.002","volume":"69","author":"N Galie","year":"2016","unstructured":"Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M (2016) 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Rev Esp Cardiol 69:177. https:\/\/doi.org\/10.1016\/j.rec.2016.01.002","journal-title":"Rev Esp Cardiol"},{"key":"2162_CR8","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","volume":"22","author":"A Grabner","year":"2015","unstructured":"Grabner A, Amaral AP, Schramm K, Singh S, Sloan A, Yanucil C, Li J, Shehadeh LA, Hare JM, David V, Martin A, Fornoni A, Di Marco GS, Kentrup D, Reuter S, Mayer AB, Pavenstadt H, Stypmann J, Kuhn C, Hille S, Frey N, Leifheit-Nestler M, Richter B, Haffner D, Abraham R, Bange J, Sperl B, Ullrich A, Brand M, Wolf M, Faul C (2015) Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy. Cell Metab 22:1020\u20131032. https:\/\/doi.org\/10.1016\/j.cmet.2015.09.002","journal-title":"Cell Metab"},{"key":"2162_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.peptides.2012.08.003","volume":"37","author":"D Gruson","year":"2012","unstructured":"Gruson D, Lepoutre T, Ketelslegers JM, Cumps J, Ahn SA, Rousseau MF (2012) C-terminal FGF23 is a strong predictor of survival in systolic heart failure. Peptides 37:258\u2013262. https:\/\/doi.org\/10.1016\/j.peptides.2012.08.003","journal-title":"Peptides"},{"key":"2162_CR10","doi-asserted-by":"publisher","first-page":"H1373","DOI":"10.1152\/ajpheart.00157.2013","volume":"305","author":"M Guazzi","year":"2013","unstructured":"Guazzi M, Bandera F, Pelissero G, Castelvecchio S, Menicanti L, Ghio S, Temporelli PL, Arena R (2013) Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. Am J Physiol Heart Circ Physiol 305:H1373\u2013H1381. https:\/\/doi.org\/10.1152\/ajpheart.00157.2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2162_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000524764","volume":"147","author":"J Han","year":"2022","unstructured":"Han J, Yuan X, Song W, Cheng Y, Lu Y, Zhang Y, Liu Y, Jiang Y (2022) The correlation of fibroblast growth factor 23 with cardiac remodeling in essential hypertension with normal renal function. Cardiology 147:271\u2013280. https:\/\/doi.org\/10.1159\/000524764","journal-title":"Cardiology"},{"key":"2162_CR12","doi-asserted-by":"publisher","first-page":"64649","DOI":"10.18632\/oncotarget.11623","volume":"7","author":"H Hao","year":"2016","unstructured":"Hao H, Li X, Li Q, Lin H, Chen Z, Xie J, Xuan W, Liao W, Bin J, Huang X, Kitakaze M, Liao Y (2016) FGF23 promotes myocardial fibrosis in mice through activation of \u03b2-catenin. Oncotarget 7:64649\u201364664. https:\/\/doi.org\/10.18632\/oncotarget.11623","journal-title":"Oncotarget"},{"key":"2162_CR13","doi-asserted-by":"publisher","first-page":"e0252833","DOI":"10.1371\/journal.pone.0252833","volume":"16","author":"T Ibe","year":"2021","unstructured":"Ibe T, Wada H, Sakakura K, Ugata Y, Maki H, Yamamoto K, Seguchi M, Taniguchi Y, Jinnouchi H, Fujita H (2021) Cardiac index predicts long-term outcomes in patients with heart failure. PLoS\u00a0One 16:e0252833. https:\/\/doi.org\/10.1371\/journal.pone.0252833","journal-title":"PLoS\u00a0One"},{"key":"2162_CR14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1681\/asn.2007060673","volume":"19","author":"T Isakova","year":"2008","unstructured":"Isakova T, Gutierrez O, Shah A, Castaldo L, Holmes J, Lee H, Wolf M (2008) Postprandial mineral metabolism and secondary hyperparathyroidism in Early CKD. J Am Soc Nephrol 19:615\u2013623. https:\/\/doi.org\/10.1681\/asn.2007060673","journal-title":"J Am Soc Nephrol"},{"key":"2162_CR15","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00467-013-2515-7","volume":"28","author":"T Isakova","year":"2013","unstructured":"Isakova T, Houston J, Santacruz L, Schiavenato E, Somarriba G, Harmon WG, Lipshultz SE, Miller TL, Rusconi PG (2013) Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure. Pediatr Nephrol 28:2035\u20132042. https:\/\/doi.org\/10.1007\/s00467-013-2515-7","journal-title":"Pediatr Nephrol"},{"key":"2162_CR16","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01192-2019","author":"S Keranov","year":"2021","unstructured":"Keranov S, Dorr O, Jafari L, Troidl C, Liebetrau C, Kriechbaum S, Keller T, Voss S, Bauer T, Lorenz J, Richter MJ, Tello K, Gall H, Ghofrani HA, Mayer E, Wiedenroth CB, Guth S, Lorchner H, Poling J, Chelladurai P, Pullamsetti SS, Braun T, Seeger W, Hamm CW, Nef H (2021) CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.01192-2019","journal-title":"Eur Respir J"},{"key":"2162_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233\u2013270. https:\/\/doi.org\/10.1093\/ehjci\/jev014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2162_CR18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1253\/circj.CJ-16-0062","volume":"80","author":"D Lazzeroni","year":"2016","unstructured":"Lazzeroni D, Rimoldi O, Camici PG (2016) From left ventricular hypertrophy to dysfunction and failure. Circ J 80:555\u2013564. https:\/\/doi.org\/10.1253\/circj.CJ-16-0062","journal-title":"Circ J"},{"key":"2162_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00278","author":"M Leifheit-Nestler","year":"2018","unstructured":"Leifheit-Nestler M, Haffner D (2018) Paracrine effects of FGF23 on the heart. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2018.00278","journal-title":"Front Endocrinol"},{"key":"2162_CR20","first-page":"300","volume":"15","author":"M Miri","year":"2021","unstructured":"Miri M, Ahmadi M, Hatami M (2021) Correlation Between fibroblast growth factor-23 and pulmonary arterial hypertension in hemodialysis patients. Iran J Kidney Dis 15:300\u2013305","journal-title":"Iran J Kidney Dis"},{"key":"2162_CR21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","volume":"207","author":"MA Mirza","year":"2009","unstructured":"Mirza MA, Larsson A, Melhus H, Lind L, Larsson TE (2009) Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis 207:546\u2013551. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.05.013","journal-title":"Atherosclerosis"},{"key":"2162_CR22","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1183\/09059180.00007414","volume":"23","author":"R Naeije","year":"2014","unstructured":"Naeije R, Manes A (2014) The right ventricle in pulmonary arterial hypertension. Eur Respir Rev Off J Eur Respir Soc 23:476\u2013487. https:\/\/doi.org\/10.1183\/09059180.00007414","journal-title":"Eur Respir Rev Off J Eur Respir Soc"},{"key":"2162_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fcvm.2017.00010","volume":"4","author":"S Niizuma","year":"2017","unstructured":"Niizuma S, Iwanaga Y, Yahata T, Miyazaki S (2017) Renocardiovascular biomarkers: from the perspective of managing chronic kidney disease and cardiovascular disease. Front Cardiovasc Med 4:10\u201310. https:\/\/doi.org\/10.3389\/fcvm.2017.00010","journal-title":"Front Cardiovasc Med"},{"key":"2162_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.07.022","author":"CB Patel","year":"2014","unstructured":"Patel CB, DeVore AD, Felker GM, Wojdyla DM, Hernandez AF, Milano CA, O\u2019Connor CM, Rogers JG (2014) Characteristics and outcomes of patients with heart failure and discordant findings by right-sided heart catheterization and cardiopulmonary exercise testing. Am J Cardiol. https:\/\/doi.org\/10.1016\/j.amjcard.2014.07.022","journal-title":"Am J Cardiol"},{"key":"2162_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1365-2362.2011.02631.x","volume":"42","author":"M Plischke","year":"2012","unstructured":"Plischke M, Neuhold S, Adlbrecht C, Bielesz B, Shayganfar S, Bieglmayer C, Szekeres T, Horl WH, Strunk G, Vavken P, Pacher R, Hulsmann M (2012) Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure. Eur J Clin Investig 42:649\u2013656. https:\/\/doi.org\/10.1111\/j.1365-2362.2011.02631.x","journal-title":"Eur J Clin Investig"},{"issue":"2016\u20132025","key":"2162_CR26","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1161\/CIRCULATIONAHA.113.001873","volume":"128","author":"S Rain","year":"2013","unstructured":"Rain S, Handoko ML, Trip P, Gan CT, Westerhof N, Stienen GJ, Paulus WJ, Ottenheijm CA, Marcus JT, Dorfmuller P, Guignabert C, Humbert M, Macdonald P, Dos Remedios C, Postmus PE, Saripalli C, Hidalgo CG, Granzier HL, Vonk-Noordegraaf A, van der Velden J, de Man FS (2013) Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation 128(2016\u20132025):2011\u20132010. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.001873","journal-title":"Circulation"},{"key":"2162_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/toxins11030175","volume":"11","author":"C Rodelo-Haad","year":"2019","unstructured":"Rodelo-Haad C, Santamaria R, Mu\u00f1oz-Casta\u00f1eda JR, Pend\u00f3n-Ruiz de Mier MV, Martin-Malo A, Rodriguez M (2019) FGF23, biomarker or target? Toxins 11:175","journal-title":"Toxins"},{"key":"2162_CR28","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1002\/ehf2.12816","volume":"7","author":"C Roy","year":"2020","unstructured":"Roy C, Lejeune S, Slimani A, de Meester C, Ahn As SA, Rousseau MF, Mihaela A, Ginion A, Ferracin B, Pasquet A, Vancraeynest D, Beauloye C, Vanoverschelde J-L, Horman S, Gruson D, Gerber BL, Pouleur A-C (2020) Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction. ESC Heart Fail 7:2494\u20132507. https:\/\/doi.org\/10.1002\/ehf2.12816","journal-title":"ESC Heart Fail"},{"key":"2162_CR29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"LG Rudski","year":"2010","unstructured":"Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr 23:685\u2013713. https:\/\/doi.org\/10.1016\/j.echo.2010.05.010","journal-title":"J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr"},{"key":"2162_CR30","doi-asserted-by":"publisher","first-page":"e73184","DOI":"10.1371\/journal.pone.0073184","volume":"8","author":"K Shibata","year":"2013","unstructured":"Shibata K, Fujita S, Morita H, Okamoto Y, Sohmiya K, Hoshiga M, Ishizaka N (2013) Association between circulating fibroblast growth factor 23, alpha-Klotho, and the left ventricular ejection fraction and left ventricular mass in cardiology inpatients. PLoS\u00a0One 8:e73184. https:\/\/doi.org\/10.1371\/journal.pone.0073184","journal-title":"PLoS\u00a0One"},{"key":"2162_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res Off J Am Soc Bone Miner Res 19:429\u2013435. https:\/\/doi.org\/10.1359\/JBMR.0301264","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"2162_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ijcard.2018.01.053","volume":"266","author":"K Tello","year":"2018","unstructured":"Tello K, Axmann J, Ghofrani HA, Naeije R, Narcin N, Rieth A, Seeger W, Gall H, Richter MJ (2018) Relevance of the TAPSE\/PASP ratio in pulmonary arterial hypertension. Int J Cardiol 266:229\u2013235. https:\/\/doi.org\/10.1016\/j.ijcard.2018.01.053","journal-title":"Int J Cardiol"},{"key":"2162_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2018.12.032","author":"K Tello","year":"2019","unstructured":"Tello K, Dalmer A, Vanderpool R, Ghofrani HA, Naeije R, Roller F, Seeger W, Wilhelm J, Gall H, Richter MJ (2019) Cardiac magnetic resonance imaging-based right ventricular strain analysis for assessment of coupling and diastolic function in pulmonary hypertension. JACC Cardiovasc Imaging. https:\/\/doi.org\/10.1016\/j.jcmg.2018.12.032","journal-title":"JACC Cardiovasc Imaging"},{"key":"2162_CR34","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1183\/09031936.00156714","volume":"45","author":"P Trip","year":"2015","unstructured":"Trip P, Rain S, Handoko ML, van der Bruggen C, Bogaard HJ, Marcus JT, Boonstra A, Westerhof N, Vonk-Noordegraaf A, de Man FS (2015) Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension. Eur Respir J 45:1603\u20131612. https:\/\/doi.org\/10.1183\/09031936.00156714","journal-title":"Eur Respir J"},{"key":"2162_CR35","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/cvr\/cvx145","volume":"113","author":"CEE van der Bruggen","year":"2017","unstructured":"van der Bruggen CEE, Tedford RJ, Handoko ML, van der Velden J, de Man FS (2017) RV pressure overload: from hypertrophy to failure. Cardiovasc Res 113:1423\u20131432. https:\/\/doi.org\/10.1093\/cvr\/cvx145","journal-title":"Cardiovasc Res"},{"key":"2162_CR36","doi-asserted-by":"publisher","first-page":"D22","DOI":"10.1016\/j.jacc.2013.10.027","volume":"62","author":"A Vonk-Noordegraaf","year":"2013","unstructured":"Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, Naeije R, Newman J, Oudiz RJ, Provencher S, Torbicki A, Voelkel NF, Hassoun PM (2013) Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol 62:D22\u2013D33. https:\/\/doi.org\/10.1016\/j.jacc.2013.10.027","journal-title":"J Am Coll Cardiol"},{"key":"2162_CR37","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jacc.2016.10.047","volume":"69","author":"A Vonk Noordegraaf","year":"2017","unstructured":"Vonk Noordegraaf A, Westerhof BE, Westerhof N (2017) The relationship between the right ventricle and its load in pulmonary hypertension. J Am Coll Cardiol 69:236\u2013243. https:\/\/doi.org\/10.1016\/j.jacc.2016.10.047","journal-title":"J Am Coll Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02162-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02162-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02162-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T05:03:32Z","timestamp":1696827812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02162-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["2162"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02162-y","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]},"assertion":[{"value":"1 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}